BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 29115437)

  • 21. E2F-1 transcriptional activity is a critical determinant of Mdm2 antagonist-induced apoptosis in human tumor cell lines.
    Kitagawa M; Aonuma M; Lee SH; Fukutake S; McCormick F
    Oncogene; 2008 Sep; 27(40):5303-14. PubMed ID: 18521084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Simvastatin induces apoptosis in human colon cancer cells and in tumor xenografts, and attenuates colitis-associated colon cancer in mice.
    Cho SJ; Kim JS; Kim JM; Lee JY; Jung HC; Song IS
    Int J Cancer; 2008 Aug; 123(4):951-7. PubMed ID: 18521906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The MDM2 Inhibitor AMG 232 Demonstrates Robust Antitumor Efficacy and Potentiates the Activity of p53-Inducing Cytotoxic Agents.
    Canon J; Osgood T; Olson SH; Saiki AY; Robertson R; Yu D; Eksterowicz J; Ye Q; Jin L; Chen A; Zhou J; Cordover D; Kaufman S; Kendall R; Oliner JD; Coxon A; Radinsky R
    Mol Cancer Ther; 2015 Mar; 14(3):649-58. PubMed ID: 25567130
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oxazoloisoindolinones with in vitro antitumor activity selectively activate a p53-pathway through potential inhibition of the p53-MDM2 interaction.
    Soares J; Pereira NA; Monteiro Â; Leão M; Bessa C; Dos Santos DJ; Raimundo L; Queiroz G; Bisio A; Inga A; Pereira C; Santos MM; Saraiva L
    Eur J Pharm Sci; 2015 Jan; 66():138-47. PubMed ID: 25312347
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Digoxin enhances radiation response in radioresistant A549 cells by reducing protein phosphatase 2A.
    Lee JY; Kim MS; Lee MS; Ju JE; Chung N; Jeong YK
    Biosci Rep; 2017 Nov; 37(6):. PubMed ID: 29070518
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elimination of hepatic metastases of colon cancer cells via p53-independent cross-talk between irinotecan and Apo2 ligand/TRAIL.
    Ravi R; Jain AJ; Schulick RD; Pham V; Prouser TS; Allen H; Mayer EG; Yu H; Pardoll DM; Ashkenazi A; Bedi A
    Cancer Res; 2004 Dec; 64(24):9105-14. PubMed ID: 15604280
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Small-molecule modulators of p53 family signaling and antitumor effects in p53-deficient human colon tumor xenografts.
    Wang W; Kim SH; El-Deiry WS
    Proc Natl Acad Sci U S A; 2006 Jul; 103(29):11003-8. PubMed ID: 16835297
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kruppel-like factor 2 mediated anti-proliferative and anti-metastasis effects of simvastatin in p53 mutant colon cancer.
    Lu L; Huang W; Hu W; Jiang L; Li Y; Wu X; Yuan D; Li M
    Biochem Biophys Res Commun; 2019 Apr; 511(4):772-779. PubMed ID: 30833076
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 2-Methoxy-5((3,4,5-trimethosyphenyl)seleninyl) phenol inhibits MDM2 and induces apoptosis in breast cancer cells through a p53-independent pathway.
    Xu J; Han M; Shen J; Guan Q; Bai Z; Lang B; Zhang H; Li Z; Zuo D; Zhang W; Wu Y
    Cancer Lett; 2016 Dec; 383(1):9-17. PubMed ID: 27693458
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glyceollins Modulate Tumor Development and Growth in a Mouse Xenograft Model of Human Colon Cancer in a
    Jeong G; Oh J; Kim JS
    J Med Food; 2019 May; 22(5):521-528. PubMed ID: 30924710
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of MDM2 inhibitors on vascular endothelial growth factor-mediated tumor angiogenesis in human breast cancer.
    Xiong J; Yang Q; Li J; Zhou S
    Angiogenesis; 2014 Jan; 17(1):37-50. PubMed ID: 23907365
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of a new class of natural product MDM2 inhibitor: In vitro and in vivo anti-breast cancer activities and target validation.
    Qin JJ; Wang W; Voruganti S; Wang H; Zhang WD; Zhang R
    Oncotarget; 2015 Feb; 6(5):2623-40. PubMed ID: 25739118
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phosphorylation of the Mdm2 oncoprotein by the c-Abl tyrosine kinase regulates p53 tumor suppression and the radiosensitivity of mice.
    Carr MI; Roderick JE; Zhang H; Woda BA; Kelliher MA; Jones SN
    Proc Natl Acad Sci U S A; 2016 Dec; 113(52):15024-15029. PubMed ID: 27956626
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The sirtuin inhibitor tenovin-6 upregulates death receptor 5 and enhances cytotoxic effects of 5-fluorouracil and oxaliplatin in colon cancer cells.
    Ueno T; Endo S; Saito R; Hirose M; Hirai S; Suzuki H; Yamato K; Hyodo I
    Oncol Res; 2013; 21(3):155-64. PubMed ID: 24512730
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Curcumin, a dietary component, has anticancer, chemosensitization, and radiosensitization effects by down-regulating the MDM2 oncogene through the PI3K/mTOR/ETS2 pathway.
    Li M; Zhang Z; Hill DL; Wang H; Zhang R
    Cancer Res; 2007 Mar; 67(5):1988-96. PubMed ID: 17332326
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circumvention and reactivation of the p53 oncogene checkpoint in mouse colon tumors.
    Aizu W; Belinsky GS; Flynn C; Noonan EJ; Boes CC; Godman CA; Doshi B; Nambiar PR; Rosenberg DW; Giardina C
    Biochem Pharmacol; 2006 Oct; 72(8):981-91. PubMed ID: 16949053
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Apoptosis-induced effects of extract from Artemisia annua Linné by modulating PTEN/p53/PDK1/Akt/ signal pathways through PTEN/p53-independent manner in HCT116 colon cancer cells.
    Kim EJ; Kim GT; Kim BM; Lim EG; Kim SY; Kim YM
    BMC Complement Altern Med; 2017 Apr; 17(1):236. PubMed ID: 28454566
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Small Molecule Inhibition of MDM2-p53 Interaction Augments Radiation Response in Human Tumors.
    Werner LR; Huang S; Francis DM; Armstrong EA; Ma F; Li C; Iyer G; Canon J; Harari PM
    Mol Cancer Ther; 2015 Sep; 14(9):1994-2003. PubMed ID: 26162687
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hinokiflavone, as a MDM2 inhibitor, activates p53 signaling pathway to induce apoptosis in human colon cancer HCT116 cells.
    Zhang S; Wang Y; Sun Y; Zhao G; Wang J; Liu L; Liu F; Wang P; Yang J; Xu X
    Biochem Biophys Res Commun; 2022 Feb; 594():93-100. PubMed ID: 35078113
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A boronic-chalcone derivative exhibits potent anticancer activity through inhibition of the proteasome.
    Achanta G; Modzelewska A; Feng L; Khan SR; Huang P
    Mol Pharmacol; 2006 Jul; 70(1):426-33. PubMed ID: 16636137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.